Rajkot News Today

Fibromyalgia Pipeline Drugs and Companies Insight Report: Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments

 Breaking News
  • No posts were found

Fibromyalgia Pipeline Drugs and Companies Insight Report: Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments

July 20
23:28 2021
Fibromyalgia Pipeline Drugs and Companies Insight Report: Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments

DelveInsight Business Research LLP
DelveInsight’s “Fibromyalgia Pipeline Insight” report provides comprehensive insights about key companies and pipeline drugs in the Fibromyalgia pipeline landscapes. It comprises Fibromyalgia pipeline drug profiles, including clinical and non-clinical stage products.

DelveInsight’s Fibromyalgia Pipeline Insight report provides comprehensive insights about key companies and pipeline drugs in the Fibromyalgia pipeline landscapes. It comprises Fibromyalgia pipeline drug profiles, including clinical and non-clinical stage products. It also includes the Fibromyalgia therapeutics assessment by product type, stage, route of administration, and molecule type and further highlights the inactive Fibromyalgia pipeline products.     

Some of the key takeaways of the Fibromyalgia Pipeline Report

  • Companies across the globe are diligently working toward the development of novel treatment therapies with a considerable amount of success over the years. Key players, such as Forest Pharmaceuticals, Pfizer Pharmaceuticals, Innovativemed concepts, Aptinyx, Astellas Pharma, etc., are developing therapies for the treatment of Fibromyalgia.

  • Emerging therapies such as Savella, LYRICA, IMC-1, NYX-2925, ASP0819, are expected to have a significant impact on the  Fibromyalgia market in the coming years.

  • IMC-1 (Innovativemed concepts) is a novel combination antiviral treatment that is designed to suppress the herpes virus. The company is currently planning to initiate a phase III study for the management of Fibromyalgia.

Get an overview of pipeline landscape @ Fibromyalgia Clinical Trials Analysis 

Fibromyalgia is a disease in which the member states are widespread musculoskeletal pain accompanied by fatigue, problems with sleep, memory, and mood. Researchers believe that fibromyalgia increases the sensation of pain, the effects in the brain and the spinal cord treatment is painful and does not cause the pain signals. 

Fibromyalgia Emerging Drugs

  1. Savella by Forest Pharmaceuticals

  2. LYRICA by Pfizer Pharmaceuticals

  3. IMC-1 by Innovativemed concepts

  4. NYX-2925 by Aptinyx

  5. ASP0819 by  Astellas Pharma

  6. And others.

Scope of Fibromyalgia Pipeline Drug Insight    

  • Coverage: Global 

  • Major Players: Forest Pharmaceuticals, Pfizer Pharmaceuticals, Innovativemed concepts, Aptinyx, Astellas Pharma, and others.

  • Pipeline Therapies: Savella, LYRICA, IMC-1, NYX-2925, ASP0819, and others.

Table of Contents

1

Fibromyalgia Report Introduction

2

Fibromyalgia Executive Summary

3

Fibromyalgia Overview

4

Fibromyalgia- Analytical Perspective In-depth Commercial Assessment

5

Fibromyalgia Pipeline Therapeutics

6

Fibromyalgia Late Stage Products (Phase II/III)

7

Fibromyalgia Mid Stage Products (Phase II)

8

Fibromyalgia Early Stage Products (Phase I)

9

Fibromyalgia Preclinical Stage Products

10

Fibromyalgia Therapeutics Assessment

11

Fibromyalgia Inactive Products

12

Company-University Collaborations (Licensing/Partnering) Analysis

13

Fibromyalgia Key Companies

14

Fibromyalgia Key Products

15

Fibromyalgia Unmet Needs

16 

Fibromyalgia Market Drivers and Barriers

17

Fibromyalgia Future Perspectives and Conclusion

18

Fibromyalgia Analyst Views

19

Appendix

20

About DelveInsight

Get a customized pipeline report @ Fibromyalgia Drugs Pipeline Report  

Related Reports:

Fibromyalgia Market 

DelveInsight’s Fibromyalgia – Market Insights, Epidemiology, and Market Forecast-2030 report deliver an in-depth understanding of the Fibromyalgia, historical and forecasted epidemiology as well as the Fibromyalgia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Fibromyalgia Epidemiology 

DelveInsight’s ‘Fibromyalgia- Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted  Fibromyalgia epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. 

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/

Related Articles